Source: W News, June 2025
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.
Led by Quanyin Hu, a professor in the UW–Madison School of Pharmacy, the research team has already found success slowing the recurrence of tumors in mouse models of triple negative breast cancer and melanoma. Currently, the long-term prognosis for human patients with these cancers is relatively poor. That’s in part because the diseases have a tendency to recur after the initial treatments to remove the tumors.